ByTrending Posts
How Can AI Transform Cancer Treatment? KOLs Insights…
Baltimore, MD — With the rapid advancement of artificial intelligence (AI), predictive medicine is becoming a pivotal part…
How Heidi Health’s $16.6M Raise Is Empowering Clinicians…
Heidi Health Secures $16.6M to Revolutionize Clinical Workflows with AI-Powered Scribe Melbourne, Australia – March 3, 2025 –…
Can Hinge Health’s $100 Million IPO Redefine AI-Powered…
San Francisco, CA – 25 May 2025 Key Highlights > IPO Launch: Hinge Health targets $100 million raise…
AI Meets Genomics: Predictive Oncology’s PEDAL™ Platform Advances…
Breakthrough aligns with Regeneron’s genomics strategy, signaling acceleration in precision oncology development PITTSBURGH, May 22, 2025 – Predictive…
How Qubit Pharmaceuticals’ Quantum AI Model FeNNix-Bio1 is…
May 23, 2025 Advancing Molecular Simulation for Faster Drug Development Qubit Pharmaceuticals, in collaboration with Sorbonne University, has…
Can AI-Powered Screening Revolutionize Cancer Detection in India?…
May 23, 2025 A Nationwide Step Toward Preventive Cancer Care Metropolis Healthcare Limited has introduced TruHealth Cancer Screen…
How are NVIDIA & Taiwan’s 22 Medical Centers…
May 18, 2025 In a landmark initiative signaling the rapid digital transformation of Asia’s healthcare ecosystem, several leading…
BioNTech to Launch £1 Billion AI-Powered R&D Hub…
Investment to Accelerate AI Innovation in Oncology, Personalized Medicine, and Drug Development May 21, 2025 Establishing an AI-Centric…
Regeneron, Sanofi & Viz.ai: How Are These Industry…
May 20, 2025 In a bold strategic alliance, Regeneron and Sanofi have teamed up with AI healthcare innovator…
Trending Posts
Latest Stories
Does Allarity Therapeutics’ Year-End Strategic Update Signal Renewed Momentum for Stenoparib in Hard-to-Treat Cancers?
Global – December 2025 — Allarity Therapeutics (NASDAQ: ALLR) has outlined key strategic and operational…
Do Wegovy Pricing Pathways in 2026 Signal a Turning Point for Obesity Drug Access and Market Expansion?
Global – December 2025 — A new pricing and access analysis for Wegovy (semaglutide) highlights…
Does FDA Approval of Nereus Mark a Long-Awaited Breakthrough for Motion-Sickness Treatment—and a Turning Point for Vanda Pharmaceuticals?
Washington, D.C. – December 2025 — Vanda Pharmaceuticals achieved a major regulatory milestone after the…
Will Axsome Therapeutics’ FDA Priority Review of AXS-05 Address a Long-Standing Gap in Alzheimer’s Disease Agitation Treatment?
New York – December 31, 2025 — Axsome Therapeutics has reached a major regulatory milestone…
Gallery
